公告 [Amend] Statement of acquisition of beneficial ownership by individuals

发表于 2024-02-06 23:23   76次浏览

公告 Current report, items 1.03, 7.01, 8.01, and 9.01

发表于 2024-02-06 23:10   87次浏览

公告 Current report, item 5.07

发表于 2024-02-01 10:58   66次浏览

公告 Additional definitive proxy soliciting materials and Rule 14(a)(12) material

发表于 2024-01-24 06:58   62次浏览

公告 Current report, items 3.03, 5.03, and 9.01

发表于 2024-01-24 06:58   59次浏览

公告 Additional definitive proxy soliciting materials and Rule 14(a)(12) material

发表于 2024-01-04 10:17   60次浏览

公告 Current report, items 7.01 and 9.01

发表于 2024-01-04 10:02   71次浏览

公告 Current report, items 5.07 and 8.01

发表于 2024-01-04 10:02   56次浏览

公告 Current report, items 1.02, 8.01, and 9.01

发表于 2023-12-22 01:49   98次浏览

公告 Additional definitive proxy soliciting materials and Rule 14(a)(12) material

发表于 2023-12-05 08:16   111次浏览

公告 Current report, items 5.07 and 8.01

发表于 2023-12-05 06:55   126次浏览

公告 Current report, items 1.02, 8.01, and 9.01

发表于 2023-11-29 06:10   80次浏览

公告 Additional definitive proxy soliciting materials and Rule 14(a)(12) material

发表于 2023-11-16 06:02   84次浏览

公告 Additional definitive proxy soliciting materials and Rule 14(a)(12) material

发表于 2023-11-16 05:46   108次浏览

公告 Current report, items 5.07 and 8.01

发表于 2023-11-16 05:35   84次浏览

公告 Additional definitive proxy soliciting materials and Rule 14(a)(12) material

发表于 2023-11-16 05:17   101次浏览

公告 Current report, items 2.02 and 9.01

发表于 2023-11-15 06:30   86次浏览

公告 Quarterly report [Sections 13 or 15(d)]

发表于 2023-11-15 05:33   87次浏览

公告 DMK Pharmaceuticals Corp|4：持股变动声明

发表于 2023-11-03 06:59   120次浏览

公告 Initial statement of beneficial ownership of securities

发表于 2023-11-03 05:10   76次浏览